Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sarcopenia and two types of presarcopenia in Japanese patients with chronic liver disease.
Hiraoka A, Michitaka K, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Yamago H, Suga Y, Tomida H, Miyamoto Y, Azemoto N, Mori K, Miyata H, Tsubouchi E, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y. Hiraoka A, et al. Among authors: yamago h. Eur J Gastroenterol Hepatol. 2016 Aug;28(8):940-7. doi: 10.1097/MEG.0000000000000661. Eur J Gastroenterol Hepatol. 2016. PMID: 27232361
Recent trends of Japanese hepatocellular carcinoma due to HCV in aging society.
Hiraoka A, Hidaka S, Shimizu Y, Utsunomiya H, Imai Y, Tatsukawa H, Tazuya N, Yamago H, Yorimitsu N, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Kawasaki H, Hirooka M, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Hepatogastroenterology. 2012 Sep;59(118):1893-5. doi: 10.5754/hge11732. Hepatogastroenterology. 2012. PMID: 22193439
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Hiraoka A, et al. Among authors: yamago h. J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250. J Gastroenterol Hepatol. 2016. PMID: 26647219
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.
Hiraoka A, Hirooka M, Koizumi Y, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Abe M, Matsuura B, Kawasaki H, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Hepatol Res. 2017 May;47(6):558-565. doi: 10.1111/hepr.12780. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27480045
Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension.
Hiraoka A, Kitahata S, Izumoto H, Ueki H, Aibiki T, Okudaira T, Miyamoto Y, Yamago H, Iwasaki R, Tomida H, Mori K, Kishida M, Tsubouchi E, Miyata H, Ninomiya T, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Hepatol Res. 2018 Feb;48(3):E354-E359. doi: 10.1111/hepr.12984. Epub 2017 Oct 18. Hepatol Res. 2018. PMID: 28940597
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.
Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y. Hiraoka A, et al. Among authors: yamago h. Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423. doi: 10.1097/MEG.0000000000000986. Eur J Gastroenterol Hepatol. 2017. PMID: 29016470
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Mori I, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19. J Gastroenterol Hepatol. 2018. PMID: 29193248
Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over a 2-year observation period.
Hiraoka A, Michitaka K, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Hiasa Y. Hiraoka A, et al. Among authors: yamago h. Hepatol Res. 2018 Jun;48(7):502-508. doi: 10.1111/hepr.13051. Epub 2018 Feb 6. Hepatol Res. 2018. PMID: 29314571
Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis.
Hiraoka A, Kumada T, Ogawa C, Kariyama K, Morita M, Nouso K, Toyoda H, Tada T, Ochi M, Murakami T, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Tomida H, Miyamoto Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Michitaka K. Hiraoka A, et al. Among authors: yamago h. J Gastroenterol Hepatol. 2019 Feb;34(2):436-441. doi: 10.1111/jgh.14378. Epub 2018 Jul 29. J Gastroenterol Hepatol. 2019. PMID: 29996177
30 results